Miriam Palomino-Pacheco

Miriam Palomino-Pacheco

Auto-generated profile, based on publicly available information

Miriam Palomino-Pacheco

Laboratory of Biochemistry, Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima 15001, Peru

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2020 in Molecules
Verified
Journal Article
Open access
PDF file
JRJuan Pedro Rojas-Armas
Juan Pedro Rojas-Armas
JAJorge Luis Arroyo Acevedo
Jorge Luis Arroyo Acevedo
MPMiriam Palomino-Pacheco
Miriam Palomino-Pacheco
Oscar Herrera-CalderonOscar Herrera-Calderon
Oscar Herrera-Calderon
JOJosé Manuel Ortiz-Sánchez
José Manuel Ortiz-Sánchez
JHJulio Hilario-Vargas
Julio Hilario-Vargas
C. citratus essential oil and carvacrol have shown an antitumor effect on breast tumor cell lines; the main objective of this research was to evaluate the antitumor effect of the essential oil of Cymbopogon citratus (EOCc) and carvacrol on 7,12-dimethylbenz [a] anthracene (DMBA)-induced breast cancer in female rats. Cancer was induced by a single administration of DMBA at dose of 80 mg/kg body weight (BW). A total of 54 female Holtzman rats were randomly assigned into 9 groups (n = 6). Group I: PS (Physiological saline); Group II: DMBA; Groups III, IV, and V: DMBA + EOCc at doses of 50, 100 and 200 mg/kg/day BW, respectively; Groups VI, VII, and VIII: DMBA + carvacrol at doses of 50, 100 and 200 mg/kg/day BW, respectively; and group IX: DMBA + EOCc + carvacrol at doses of 100 mg/kg/day BW. The treatment lasted 14 weeks. As results, EOCc showed a reduction in tumors as well as necrosis and mitosis. Animals treated with carvacrol did not show necrosis, mitosis, or infiltration. Carvacrol at dose of 100 mg/kg/day BW revealed a significant decrease in the cumulative tumor volume down to 0.11 ± 0.05 cm3 compared to 0.38 ± 0.04 cm3 of the DMBA group (p < 0.01). It is concluded that EOCc and carvacrol had an antitumor effect on DMBA-induced breast cancer in female rats.

1 January 2020 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
Oscar Herrera-CalderonOscar Herrera-Calderon
Oscar Herrera-Calderon
AYAndres F. Yepes-Pérez
Andres F. Yepes-Pérez
JQJORGE QUINTERO-SAUMETH
JORGE QUINTERO-SAUMETH
JRJuan Pedro Rojas-Armas
Juan Pedro Rojas-Armas
MPMiriam Palomino-Pacheco
Miriam Palomino-Pacheco
VAVIDALINA ANDIA
VIDALINA ANDIA
Carvacrol is a phenol monoterpene found in aromatic plants specially in Lamiaceae family, which has been evaluated in an experimental model of breast cancer. However, any proposed mechanism based on its antitumor effect has not been reported. In our previous study, carvacrol showed a protective effect on 7,12‐dimethylbenz[α]anthracene‐ (DMBA‐) induced breast cancer in female rats. The main objective in this research was to evaluate by using in silico study the carvacrol on HER2, PI3Kα, mTOR, hER‐α, PR, and EGFR receptors involved in breast cancer progression by docking analysis, molecular dynamic, and drug‐likeness evaluation. A multilevel computational study to evaluate the antitumor potential of carvacrol focusing on the main targets involved in the breast cancer was carried out. The in silico study starts with protein‐ligand docking of carvacrol followed by ligand pathway calculations, molecular dynamic simulations, and molecular mechanics energies combined with the Poisson–Boltzmann (MM/PBSA) calculation of the free energy of binding for carvacrol. As result, the in silico study led to the identification of carvacrol with strong binding affinity on mTOR receptor. Additionally, in silico drug‐likeness index for carvacrol showed a good predicted therapeutic profile of druggability. Our findings suggest that mTOR signaling pathway could be responsible for its preventive effect in the breast cancer.

10 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
JRJuan Pedro Rojas-Armas
Juan Pedro Rojas-Armas
JAJorge Luis Arroyo Acevedo
Jorge Luis Arroyo Acevedo
MPMiriam Palomino-Pacheco
Miriam Palomino-Pacheco
JOJosé Manuel Ortiz-Sánchez
José Manuel Ortiz-Sánchez
James CalvaJames Calva
James Calva
Oscar Herrera-CalderonOscar Herrera-Calderon
Oscar Herrera-Calderon
Annona muricata leaves are traditionally used as an anticancer plant in the world. The aim of this study was to evaluate the ameliorative effect of the essential oil from Annona muricata leaves (EOAm) in an experimental model of breast cancer and to determine the volatile constituents with gas chromatography-mass spectrometry (GC-MS). Thirty female rats were assigned to five groups: the control group; the DMBA (7,12-dimethylbenz[α]anthracene) group; and three groups received daily EOAm doses of 50, 100, and 200 mg/kg/day, plus DMBA, respectively. After 13 weeks of treatment, tumors were analyzed pathologically and biochemical markers in serum were noted. As a result, in GC-MS analysis, 40 compounds were identified and 4 of them were abundant: Z-caryophyllene (40.22%), followed by α-selinene (9.94%), β-pinene (8.92%), and β-elemene (7.48%). Furthermore, EOAm in a dose-dependent form produced a reduction in tumor frequency and the accumulated tumor volume was reduced by 50% and 71% with doses of 100 and 200 mg/kg, respectively. Serum levels of reduced glutathione (GSH) increased and malondialdehyde (MDA) decreased significantly compared to the DMBA group. Serum levels of vascular endothelial growth factor (VEGF) decreased significantly from 70.75 ± 7.15 pg/mL in the DMBA group to 46.50 ± 9.00 and 34.13 ± 11.50 pg/mL in groups treated with doses of 100 and 200 mg/kg, respectively. This study concludes that the EOAm leaves showed an ameliorative effect in a murine model of breast cancer.

7 July 2024 in Veterinary World
Verified
Journal Article
Open access
MPMiriam Palomino-Pacheco
Miriam Palomino-Pacheco
JRJuan Pedro Rojas-Armas
Juan Pedro Rojas-Armas
JOJosé Manuel Ortiz-Sánchez
José Manuel Ortiz-Sánchez
JAJorge Luis Arroyo Acevedo
Jorge Luis Arroyo Acevedo
Hugo Jesús Justil-GuerreroHugo Jesús Justil-Guerrero
Hugo Jesús Justil-Guerrero
JMJaime Teodocio Martínez-Heredia
Jaime Teodocio Martínez-Heredia
Background and Aim: Although widely employed in traditional remedies globally, the safety and efficacy of Moringa oleifera remain inadequately documented through scientific research. This study evaluated the oral toxicity of M. oleifera leaf aqueous extract (MoAE) and its impact on gout-induced rats. Materials and Methods: 2000 mg/kg was given in a single dose during the acute oral toxicity test, while 100 mg/kg, 250 mg/kg, and 500 mg/kg were given daily for 28 days in the repeated dose toxicity test. 100 mg/kg, 250 mg/kg, and 500 mg/kg MoAE doses were administered during the assessment of its impact on gout caused by monosodium urate. In the hyperuricemia model induced by oxonic acid, serum uric acid levels were assessed and pain response was measured through acetic acid-induced writhing. Results: In acute oral and 28-day repeated dose tests, no indications of toxicity were detected, while MoAE alleviated ankle joint swelling and reduced serum uric acid concentrations in arthritic rats, causing a significant reduction in acetic acid-induced contortions. Conclusion: No acute oral toxicity or toxicity in 28-day repeated doses was found for MoAE, while it exhibited antiarthritic, antihyperuricemic, and pain-relieving effects in the murine model. Keywords: extract, gout, Moringa oleifera, murine, toxicity.

20 March 2024 in Molecules
Verified
Journal Article
Open access
PDF file
JRJuan Pedro Rojas-Armas
Juan Pedro Rojas-Armas
MPMiriam Palomino-Pacheco
Miriam Palomino-Pacheco
JAJorge Luis Arroyo Acevedo
Jorge Luis Arroyo Acevedo
JOJosé Manuel Ortiz-Sánchez
José Manuel Ortiz-Sánchez
Hugo Jesús Justil-GuerreroHugo Jesús Justil-Guerrero
Hugo Jesús Justil-Guerrero
ALDO JAVIER GUZMAN DUXTANALDO JAVIER GUZMAN DUXTAN
ALDO JAVIER GUZMAN DUXTAN
Moringa oleifera Lam, commonly known as moringa, is a plant widely used both as a human food and for medicinal purposes around the world. This research aimed to evaluate the efficacy of the aqueous extract of Moringa oleifera leaves (MoAE) and benzyl isothiocyanate (BIT) in rats with induced breast cancer. Cancer was induced with 7,12-dimethylbenz[a]anthracene (DMBA) at a dose of 60 mg/kg by orogastric gavage once only. Forty-eight rats were randomly assigned to eight groups, each consisting of six individuals. The control group (healthy) was called Group I. Group II received DMBA plus saline. In addition to DMBA, Groups III, IV, and V received MoAE at 100, 250, and 500 mg/kg/day, respectively, while Groups VI, VII, and VIII received BIT at 5, 10, and 20 mg/kg/day, respectively. Treatment was carried out for 13 weeks. Secondary metabolite analysis results identified predominantly quercetin, caffeoylquinic acid, neochlorogenic acid, vitexin, and kaempferol, as well as tropone, betaine, loliolide, and vitexin. The administration of MoAE at a dose of 500 mg/kg and BIT at 20 mg/kg exhibited a notable decrease in both the total tumor count and the cumulative tumor weight, along with a delay in their onset. Furthermore, they improved the histological grade. A significant decrease in serum levels of VEGF and IL-1β levels was observed (p < 0.001) with a better effect demonstrated with MoAE at 500 mg/kg and BIT at 20 mg/kg. In conclusion, this study suggests that both the aqueous extract of Moringa oleifera leaves and the benzyl isothiocyanate possess antitumor properties against mammary carcinogenesis, and this effect could be due, at least in part, to the flavonoids and isothiocyanates present in the extract.

21 October 2024 in Molecules
Verified
Journal Article
Open access
PDF file
Hugo Jesús Justil-GuerreroHugo Jesús Justil-Guerrero
Hugo Jesús Justil-Guerrero
JAJorge Luis Arroyo Acevedo
Jorge Luis Arroyo Acevedo
JRJuan Pedro Rojas-Armas
Juan Pedro Rojas-Armas
CBCARLOS ORLANDO GARCIA BUSTAMANTE
CARLOS ORLANDO GARCIA BUSTAMANTE
MPMiriam Palomino-Pacheco
Miriam Palomino-Pacheco
James CalvaJames Calva
James Calva
Chronic disease inflammation requires safe complementary treatments. The pericarp of Passiflora tripartita var. mollissima (PTM) contains potential anti-inflammatory metabolites. This study aimed to evaluate the bioactive components, antioxidant capacity, and anti-inflammatory effects of PTM extracts at two ripening stages. The bioactive compounds in the hydrophilic and lipophilic extracts of mature and green pericarps were identified by GC-MS and UV–VIS, while the antioxidant capacity was measured by free radical reduction. Anti-inflammatory effects were tested using a rat paw edema model with carrageenan-induced edema, indomethacin, or PTM extracts (100, 250, and 500 mg/kg). The effect of mature hydrophilic extract was further evaluated in an air pouch model, where rats received the placebo, carrageenan, indomethacin, or the extract (500 and 1000 mg/kg). Leukocytes, cytokines, and markers of oxidative stress were evaluated. The results showed the presence of organic compounds, total phenols, and flavonoids. The mature hydrophilic extract exhibited the highest antioxidant activity. At 500 mg/kg, it reduced edema, leukocyte migration, and levels of IL-1β, IL-6, and TNF-α while managing oxidative stress and preventing histological damage. In conclusion, PTM contains bioactive compounds with potential pharmacological properties. The hydrophilic extract of the mature pericarp, at a dose of 500 mg/kg, exhibits an enhanced antioxidant and anti-inflammatory effect.